Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 2926 - 2950 of 3204 in total
Vixotrigine has been investigated for the treatment of Bipolar Disorder and Bipolar Depression.
Investigational
A metabolite from Penicillium brefeldianum that exhibits a wide range of antibiotic activity.
Experimental
Experimental
Experimental
The compound, named BILN 2061, is an orally active inhibitor of the HCV NS3 protease and the first member of this new drug class to be tested in humans.
Investigational
ALK-4290 is under investigation in clinical trial NCT03558061 (Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration).
Investigational
Cinolazepam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. It is not approved in Canada or America.
Experimental
Nutraceutical
Sabarubicin has been used in trials studying the treatment of Prostate Cancer, Testicular Germ Cell Tumor, and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Vincamine is a monoterpenoid indole alkaloid obtained from the leaves of Vinca minor with a vasodilatory property. Studies indicate that vincamine increases the regional cerebral blood flow.
Experimental
CE-326,597 has been used in trials studying the treatment of Obesity.
Investigational
Displaying drugs 2926 - 2950 of 3204 in total